Teyi Pharmaceutical Group Co.,Ltd

Shenzhen Stock Exchange 002728.SZ

Teyi Pharmaceutical Group Co.,Ltd Market Capitalization on January 14, 2025: USD 581.59 M

Teyi Pharmaceutical Group Co.,Ltd Market Capitalization is USD 581.59 M on January 14, 2025, a -20.70% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Teyi Pharmaceutical Group Co.,Ltd 52-week high Market Capitalization is USD 823.44 M on April 01, 2024, which is 41.58% above the current Market Capitalization.
Teyi Pharmaceutical Group Co.,Ltd 52-week low Market Capitalization is USD 495.31 M on September 18, 2024, which is -14.84% below the current Market Capitalization.
Teyi Pharmaceutical Group Co.,Ltd average Market Capitalization for the last 52 weeks is USD 622.29 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Shenzhen Stock Exchange: 002728.SZ

Teyi Pharmaceutical Group Co.,Ltd

CEO	Mr. Songqing Xu
IPO Date	July 31, 2014
Location	China
Headquarters	No. 9, 11, Changxing Road
Employees	1,243
Sector	Health Care
Industries Pharmaceuticals Chemicals & Advanced Materials

Description

Teyi Pharmaceutical Group Co., Ltd. engages in the research and development, production, and sale of proprietary Chinese medicines, and chemical preparations, raw materials, and products in China. The company offers cough and phlegm, kidney, anti- infection, cardiovascular, and digestive system drugs. Its chemical raw materials and products include aluminum magnesium carbonate, phenytoin, ferrous sulfate, glacial acetic acid, calcium chloride, sodium chloride, bismuth series, citric acid series, zinc sulfate, etc. The company was formerly known as Guangdong Taicheng Pharmaceutical Co., Ltd. and changed its name to Teyi Pharmaceutical Group Co., Ltd. in November 2016. Teyi Pharmaceutical Group Co., Ltd. is based in Taishan, China.

Key trends

Past 5 years